What is the appropriate management for a Parkinson's disease patient who develops hypertonia and brisk tendon reflexes after their Parkinson's medications were held?

Parkinsonism-Hyperpyrexia Syndrome (Neuroleptic Malignant Syndrome-Like): Immediate Medication Reinitiation Required

This patient is experiencing parkinsonism-hyperpyrexia syndrome (also called neuroleptic malignant syndrome-like syndrome), a potentially life-threatening complication of abrupt Parkinson's medication withdrawal that requires immediate reinstitution of dopaminergic therapy.

Clinical Recognition

The presentation of hypertonia and brisk reflexes after holding Parkinson's medications represents a medical emergency distinct from typical drug-induced parkinsonism:

• Neuroleptic malignant syndrome (NMS) features a tetrad: mental status changes, fever, hypertonicity/rigidity, and autonomic dysfunction, caused by lack of dopaminergic activity in the CNS 1
• Parkinsonism-hyperpyrexia syndrome occurs when dopaminergic medications are withdrawn or reduced in Parkinson's disease patients, mimicking NMS 1
• The pathophysiology involves dopamine D2 receptor deficiency in the hypothalamus (producing fever and loss of heat dissipation), nigrostriatal pathways (producing rigidity), and peripheral sarcoplasmic reticulum calcium release (causing increased muscle contractility and rigidity) 1

Immediate Management Algorithm

Step 1: Recognize the Emergency

• Assess for the complete tetrad: altered mental status, fever, muscle rigidity (hypertonia), and autonomic instability 1
• Brisk reflexes in this context represent upper motor neuron signs from severe rigidity, not typical parkinsonian findings 2
• Differentiate from drug-induced parkinsonism, which presents with bradykinesia, tremors, and rigidity but without fever or acute mental status changes 3

Step 2: Restart Dopaminergic Therapy Immediately

• Reinstitute the patient's previous Parkinson's medications at their prior doses without delay 1
• Early diagnosis and rapid withdrawal reversal (i.e., medication reinitiation) improves the possibility of complete recovery 1
• Do not wait for laboratory confirmation or further diagnostic workup before restarting medications

Step 3: Supportive Care

• Provide aggressive cooling measures if fever is present 1
• Ensure adequate hydration and monitor for rhabdomyolysis (elevated creatine kinase, myoglobinuria) 1
• Monitor vital signs continuously for autonomic instability 1

Step 4: Consider Adjunctive Therapies

• If unable to administer oral medications or if symptoms are severe, consider dopaminergic agonists like amantadine 3
• Anticholinergic agents may provide additional benefit for rigidity 3

Critical Pitfalls to Avoid

Never abruptly discontinue Parkinson's medications without a clear plan for monitoring and management, as this can precipitate parkinsonism-hyperpyrexia syndrome 1. This is fundamentally different from drug-induced parkinsonism from antipsychotics, where the causative agent should be discontinued 3, 1.

The presence of brisk reflexes distinguishes this from typical Parkinson's disease, where reflexes are usually normal or diminished 4, 2. However, some studies show that increased tendon jerks can occur in idiopathic Parkinson's disease (41 of 119 patients had 3+ reflexes at two or more sites), though this is a chronic finding rather than an acute change 2.

Prognosis and Monitoring

Parkinsonism-hyperpyrexia syndrome is potentially lethal if not recognized and treated promptly 1. Once medications are restarted:

• Monitor for clinical improvement in rigidity, mental status, and fever over 24-48 hours 1
• Continue monitoring creatine kinase levels until normalized 1
• Ensure the patient never experiences abrupt medication withdrawal again 1

The key distinction from antipsychotic-induced parkinsonism is that in Parkinson's disease patients, the treatment is to restart dopaminergic medications, not to discontinue them 1. This represents a reversal of the typical approach to drug-induced movement disorders.